Anti-CD36 antibodies in thrombotic thrombocytopenic purpura.
about
Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpuraPathophysiology of thrombotic thrombocytopenic purpuraInduction of microthrombotic thrombocytopenia in normal mice by transferring a platelet-reactive, monoclonal anti-gp70 autoantibody established from MRL/lpr mice: an autoimmune model of thrombotic thrombocytopenic purpura.Management of thrombotic thrombocytopenic purpura.Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells.Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease.Control of von Willebrand factor multimer size by thrombospondin-1.New aspects in the pathogenesis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.Plasma from patients with thrombotic thrombocytopenic purpura induces activation of human monocytes and polymorphonuclear neutrophils.Platelet recovery rate during plasma exchange predicts early and late responses in patients with thrombotic thrombocytopenic purpura.Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research.Life-threatening complications of adult-onset Still's disease.Apheresis in grade 4 bone marrow transplant associated thrombotic microangiopathy: a case series.Thrombotic thrombocytopenic purpura plasma enhances platelet-leucocyte interaction in vitro.Anti-CD36 autoantibodies in thrombotic thrombocytopenic purpura and other thrombotic disorders: identification of an 85 kD form of CD36 as a target antigen.Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group.Expression of CD markers' in immune thrombocytopenic purpura: prognostic approaches.Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus.Current Clinical Practice: Current Management of Thrombotic Thrombocytopenic Purpura.
P2860
Q24614077-5025434B-F8C5-4840-9FE3-8750A662831FQ24614117-494C5F82-1137-4555-B288-9378238E1FD3Q33331009-247E689A-4B7E-4C20-A6A0-945E1F28D5E5Q33333063-D5077EF8-38D8-4746-B23D-B4E2061B6830Q33335746-ECD204A8-8237-4CDB-BD2D-CD8587D1D4C3Q33335807-70064A60-7FEF-4AE9-B293-4C3E0901FEBEQ33337783-2CC18B14-BA90-409E-B62E-40B8A24B5EB5Q33339749-C7986E45-97AC-40FF-B10F-495F0B13FB53Q33345792-AE459778-81B7-4CE4-9B2E-9ED7482D93FFQ33402876-E407BDDD-4F56-442C-9471-EDB3F33B1C6CQ33411009-FF6AD498-A5D9-4C02-BF6A-C2D6E11217D9Q33412732-05E9B19A-534B-45DC-9FD5-F02770B3D27EQ33498152-10C4C9C7-429C-444C-9EC6-8EBF7FE5CEAEQ33501513-9AF53F94-F4E9-48E6-9C5A-E08FCB3F8A7BQ33504686-9D8309A5-210C-4F75-B491-241696159C50Q33504909-496F71F3-F003-4A58-8453-06AE6BA3B2E7Q47727224-34E2F612-20B4-4E62-8B49-9A2D3297C0D7Q47849248-6BA70F25-5C76-4B63-AB4E-125751B6E3DCQ54394972-22620AC5-D2C9-4AB2-8EB7-6406A212C67E
P2860
Anti-CD36 antibodies in thrombotic thrombocytopenic purpura.
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Anti-CD36 antibodies in thrombotic thrombocytopenic purpura.
@ast
Anti-CD36 antibodies in thrombotic thrombocytopenic purpura.
@en
type
label
Anti-CD36 antibodies in thrombotic thrombocytopenic purpura.
@ast
Anti-CD36 antibodies in thrombotic thrombocytopenic purpura.
@en
prefLabel
Anti-CD36 antibodies in thrombotic thrombocytopenic purpura.
@ast
Anti-CD36 antibodies in thrombotic thrombocytopenic purpura.
@en
P2093
P2860
P1476
Anti-CD36 antibodies in thrombotic thrombocytopenic purpura.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2141.1994.TB05122.X
P407
P577
1994-12-01T00:00:00Z